INVISION AG/ DE0005859698 /
2024-02-22 8:45:06 AM | Chg. - | Volume | Bid10:00:00 PM | Ask10:00:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
5.700EUR | - | 0 Turnover: 0.000 |
-Bid Size: - | -Ask Size: - | 13.07 mill.EUR | 0.00% | - |
GlobeNewswire
2022-03-17
Inivata and Collaborators Publish Clinical Validation Data for RaDaR™ Assay in Non-Small Cell Lung C...
GlobeNewswire
2022-02-11
Inivata and Collaborators Publish Positive Results from Prospective Clinical Study of RaDaR™ in Head...
GlobeNewswire
2022-01-11
Inivata Announces RaDaR™ Assay Receives CE Mark and is Submitted for US Reimbursement via the MolDX ...
GlobeNewswire
2021-10-19
Inivata Announces Clinical Collaboration with Princess Margaret Cancer Center for the use of its Liq...
GlobeNewswire
2021-09-09
Inivata and collaborators to present data that further validate the application of its RaDaR™ MRD an...
GlobeNewswire
2021-07-07
SBA Hosts National SBIR Week to Connect Technology Innovators & Entrepreneurs with Research Funding
GlobeNewswire
2021-05-25
Inivata Announces Collaboration with F-star Therapeutics for the use of RaDaRTM Assay
GlobeNewswire
2021-04-28
Inivata and Agendia Sign Agreement for Commercialization of RaDaR® MRD Liquid Biopsy Assay in Breast...
GlobeNewswire
2021-04-10
Inivata Presents New Data in Support of its Liquid Biopsy Technologies at AACR Virtual Annual Meetin...
GlobeNewswire
2021-03-17
Inivata to Present New Data in Support of its RaDaR™ MRD and InVisionFirst®-Lung tests at AACR Virtu...
GlobeNewswire
2021-01-20
First Patients Tested with InVisionFirst®-Lung in EORTC Sponsored Phase II NSCLC Study
GlobeNewswire
2020-12-18
Inivata’s Liquid Biopsy Technology Included in Unique £10m Research Collaboration for Early Detectio...
GlobeNewswire
2020-10-29
Inivata Announces Collaboration with Maverick Therapeutics for use of RaDaR™ Assay